Drugs Made In America Acquisition II Corp. - Right (DMIIR) is listed on NASDAQ in the Finance, Insurance & Real Estate sector. This page tracks real-time DMIIR price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
RSI (14) 52.4 Neutral
Market Cap $5.1M
Volume 955
Fundamentals — 10-Q Q1 2026
Revenue --
Net Income $4.3M
EPS --
Other Bank Stocks
- JPM JP Morgan Chase & Co.
- BAC Bank of America Corporation
- WFC Wells Fargo & Company
- IBACR IB Acquisition Corp. - Right
- AMUB ETRACS Alerian MLP Index ETN Series B due July 18, 2042
- RFAIR RF Acquisition Corp II - Right
- AXINR Axiom Intelligence Acquisition Corp 1 - Right
- KCHVR Kochav Defense Acquisition Corp. - Right
Take DMIIR further
- Browse Bank Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put DMIIR in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Drugs Made In America Acquisition II Corp. - Right next reports.
Set alerts on DMIIR
Get notified when Drugs Made In America Acquisition II Corp. - Right hits your price targets or technical conditions are met.
Get Started Free